Skip to content

13F-HR filed by TANG CAPITAL MANAGEMENT LLC

TANG CAPITAL MANAGEMENT LLC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 95 holding rows worth $815,421,000.

Accession
0001214659-22-013682
Filed
2022-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 95 entries on the cover page, a total value of $815,421,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $815,421,000 with VALUE read as thousands by filing date, 13F file number 028-14822. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ANAPTYSBIO INC032724106COM2,628,678$67,058,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM280,000$42,328,000thousands by filing date
BLUEBIRD BIO INC09609G100COM6,335,528$40,104,000thousands by filing date
TARSUS PHARMACEUTICALS INC87650L103COMMON STOCK2,089,856$35,778,000thousands by filing date
ALTIMMUNE INC02155H200COM NEW2,600,450$33,208,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK640,000$29,779,000thousands by filing date
HERON THERAPEUTICS INC427746102COM6,840,000$28,865,000thousands by filing date
BIO RAD LABS INC090572207CL A64,000$26,697,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM1,800,000$26,118,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK1,099,516$21,287,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM1,265,900$20,204,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock100,000$20,016,000thousands by filing date
IMMUNOCORE HLDGS PLC ADS45258D105ADR405,600$19,039,000thousands by filing date
VIRIDIAN THERAPEUTICS INC92790C104COM882,925$18,109,000thousands by filing date
ITEOS THERAPEUTICS INC46565G104COM937,500$17,859,000thousands by filing date
BIOATLA INC09077B104COM1,967,051$15,146,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock1,200,000$15,120,000thousands by filing date
RELMADA THERAPEUTICS INC75955J402COMMON STOCK400,000$14,808,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR105,000$14,156,000thousands by filing date
HARMONY BIOSCIENCES HLDGS IN413197104COM310,000$13,730,000thousands by filing date
TWITTER INC90184L102COM300,000$13,152,000thousands by filing date
Veru Inc92536C103Common Stock1,100,000$12,672,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock500,000$10,770,000thousands by filing date
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR224,950$9,592,000thousands by filing date
MIRUM PHARMACEUTICALS INC604749101COM450,000$9,455,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock200,000$8,846,000thousands by filing date
NKARTA INC65487U108COMMON STOCK662,872$8,723,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR150,000$8,226,000thousands by filing date
ALLAKOS INC01671P100COM1,323,393$8,099,000thousands by filing date
Day One Biopharmaceuticals Inc23954D109Common Stock400,000$8,012,000thousands by filing date
CULLINAN THERAPEUTICS INC230031106COM624,016$8,000,000thousands by filing date
REVANCE THERAPEUTICS INC761330109COM287,500$7,763,000thousands by filing date
KINIKSA PHARMACEUTICALS LTDG5269C101COM CL A600,000$7,704,000thousands by filing date
COHERUS ONCOLOGY INC19249H103COM750,000$7,208,000thousands by filing date
IMMUNOGEN INC45253H101COMMON STOCK1,500,000$7,170,000thousands by filing date
ENANTA PHARMACEUTICALS INC29251M106COM137,700$7,142,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR66,090$6,824,000thousands by filing date
TCR2 THERAPEUTICS INC87808K106COM3,741,606$6,735,000thousands by filing date
CONCERT PHARMACEUTICALS INC206022105COM1,003,017$6,720,000thousands by filing date
BRIDGEBIO PHARMA INC10806X102COM585,424$5,819,000thousands by filing date
ARCUS BIOSCIENCES INC03969F109COM200,000$5,232,000thousands by filing date
CYTOMX THERAPEUTICS INC23284F105COMMON STOCK3,500,000$5,075,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW160,219$4,504,000thousands by filing date
GENFIT S A372279109ADS1,197,522$4,371,000thousands by filing date
2SEVENTY BIO INC COMMON STOCK901384107Stock300,000$4,365,000thousands by filing date
BIONTECH SE SPONSORED ADS09075V102ADR30,000$4,046,000thousands by filing date
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS50,000$4,000,000thousands by filing date
HEALTH SCIENCES ACQ CORP 2G4411D109ORD SHS392,500$3,886,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM700,000$3,738,000thousands by filing date
FORTRESS BIOTECH INC34960Q109COM4,194,483$3,607,000thousands by filing date
GRAPHITE BIO INC38870X104COM1,100,000$3,487,000thousands by filing date
SPRINGWORKS THERAPEUTICS INC85205L107COM120,000$3,424,000thousands by filing date
ASLAN PHARMACEUTICALS LTD04522R101ADR5,654,925$3,386,000thousands by filing date
ESPERION THERAPEUTICS INC NEW COM29664W105Stock500,000$3,350,000thousands by filing date
ATYR PHARMA INC002120202COM NEW1,113,453$3,340,000thousands by filing date
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock50,000$3,268,000thousands by filing date
LEGEND BIOTECH CORP52490G102SPONSORED ADS80,000$3,264,000thousands by filing date
ANI PHARMACEUTICALS INC00182C103COM100,000$3,214,000thousands by filing date
EAGLE PHARMACEUTICALS INC269796108COM118,857$3,140,000thousands by filing date
AXSOME THERAPEUTICS INC. COM05464T104Stock70,000$3,123,000thousands by filing date
CLENE INC185634102COM1,100,000$3,080,000thousands by filing date
GOSSAMER BIO INC COM38341P102Stock250,000$2,995,000thousands by filing date
PYXIS ONCOLOGY INC COMMON STOCK747324101Stock1,411,569$2,781,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM40,000$2,636,000thousands by filing date
CHEMOCENTRYX INC16383L106COM50,000$2,583,000thousands by filing date
VANDA PHARMACEUTICALS INC921659108COM256,696$2,536,000thousands by filing date
ADMA BIOLOGICS INC000899104COM992,840$2,413,000thousands by filing date
BEAM THERAPEUTICS INC07373V105COM50,000$2,382,000thousands by filing date
ARS PHARMACEUTICALS INC82835W108COM409,463$2,162,000thousands by filing date
BELLUS HEALTH INC NEW07987C204COM200,000$2,112,000thousands by filing date
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock259,054$2,010,000thousands by filing date
ALIGOS THERAPEUTICS INC COM NEW01626L105Stock1,674,166$1,842,000thousands by filing date
CTI BIOPHARMA CORP12648L601COM300,000$1,746,000thousands by filing date
Tscan Therapeutics Inc89854M101COM557,915$1,702,000thousands by filing date
AURINIA PHARMACEUTICALS INC COM05156V102Stock200,000$1,504,000thousands by filing date
INSPIRATO INCORPORATED45791E107COM612,345$1,445,000thousands by filing date
VINCERX PHARMA INC92731L106COM NEW1,030,634$1,422,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM20,000$1,397,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM430,037$1,376,000thousands by filing date
EQUILLIUM INC29446K106COM600,000$1,332,000thousands by filing date
TRITIUM DCFC LIMITEDQ9225T108ORDINARY SHARES400,000$1,276,000thousands by filing date
LEAP THERAPEUTICS INC52187K101COM1,250,000$1,100,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158201COM NEW100,000$1,044,000thousands by filing date
ORCHARD THERAPEUTICS PLC68570P101ADR2,000,000$1,000,000thousands by filing date
ALECTOR INC014442107COMMON STOCK100,000$946,000thousands by filing date
PARDES BIOSCIENCES INC69945Q105COM500,000$925,000thousands by filing date
ARVINAS INC04335A105COM20,000$890,000thousands by filing date
OLEMA PHARMACEUTICALS INC68062P106COM318,926$880,000thousands by filing date
METACRINE INC59101E103COM1,718,220$833,000thousands by filing date
TRANSPORTATION & LOGISTI438083107COM214,898$346,000thousands by filing date
BOLT BIOTHERAPEUTICS INC097702104COM200,000$296,000thousands by filing date
EVOLUS INC30052C107COM36,514$294,000thousands by filing date
MOLECULAR PARTNERS AG60853G106ADS15,681$105,000thousands by filing date
INSPIRATO INCORPORATED45791E115*W EXP 02/11/202365,000$88,000thousands by filing date
ACELRX PHARMACEUTICALS INC00444T100COM388,468$81,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-22-013682this filing2022-11-14acceptance time not in the bulk data set